China Universal Asset Management Company’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
SCM
N
China Universal Asset Management Company's EWTX Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Edgewise Therapeutics (EWTX) stake by 28% in Q2 2026, selling an estimated $243K and leaving 18,373 shares worth $746K. The position accounts for 0.04% of the portfolio, ranked #231.
China Universal Asset Management Company first reported a position in EWTX in Q3 2022 and has held it in 16 quarters since. The position peaked at $801K in Q1 2026. 105 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.
- China Universal Asset Management Company held 18,373 shares of Edgewise Therapeutics worth $746K as of Q2 2026.
- China Universal Asset Management Company sold 7,063 Edgewise Therapeutics shares in Q2 2026, an estimated $243K.
- Edgewise Therapeutics made up 0.04% of China Universal Asset Management Company's portfolio in Q2 2026, its #231 holding.
- China Universal Asset Management Company first reported a position in Edgewise Therapeutics in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Edgewise Therapeutics position peaked at $801K in Q1 2026.
- 105 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.